Showing results (51-60 of 354) with videos related to
Sort By:
Pageof 36
Frontiers in Oncology|March 30, 2023
Cancer, more than a "COVID-19 co-morbidity"Chinmay T Jani, Robert T Schooley, Rana R Mckay, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2005
Phase III prostate cancer prevention trials: are the costs justified?Ian M Thompson, Catherine M Tangen, Eric A Klein, et al.Future Oncology (London, England)|July 23, 2015
Cardio-oncology: an ongoing evolutionBradley J Petek, Chris Greenman, Joerg Herrmann, et al.Texas Heart Institute Journal|July 2, 2011
Cardiac dysfunction after cancer treatmentMichael S Ewer, Sandra M Swain, Daniela Cardinale, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Peroxisome proliferator-activated receptor-gamma suppresses cyclooxygenase-2 expression in human prostate cellsAnita L Sabichi, Vemparala Subbarayan, Norma Llansa, et al.Cancer Treatment Reviews|March 24, 2024
If it's a target, it's a pan-cancer target: Tissue is not the issueJacob J Adashek, Shumei Kato, Jason K Sicklick, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 25, 2020
Cancer patients in cardiology: how to communicate with patients with special psychological needs and manage their cardiac problems in daily clinical practiceChiara Lestuzzi, Maria Antonietta Annunziata, Anju Nohria, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2005
Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemopreventionAndrew J Dannenberg, Scott M Lippman, Jason R Mann, et al.European Urology|December 4, 2003
Prevention of prostate cancer with finasteride: US/European perspectiveIan M Thompson, Eric A Klein, Scott M Lippman, et al.Carcinogenesis|April 19, 2014
Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology studyYonggang He, Yilei Gong, Jian Gu, et al.Pageof 36